These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 6504897)

  • 1. Management of flat carcinoma in situ of the bladder.
    Whitmore WF
    Prog Clin Biol Res; 1984; 162B():219-24. PubMed ID: 6504897
    [No Abstract]   [Full Text] [Related]  

  • 2. Treatment of superficial carcinoma of the bladder.
    Paulson DF
    Prog Clin Biol Res; 1984; 162B():193-209. PubMed ID: 6209720
    [No Abstract]   [Full Text] [Related]  

  • 3. BCG in the management of superficial bladder cancer.
    Guinan P; Richardson C; Hanna M; Rubenstein M
    Prog Clin Biol Res; 1989; 303():447-53. PubMed ID: 2675002
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A comparative study of BCG and mitomycin C in superficial carcinomas of the bladder].
    Iavarone C; Minocchi L; Arecchi S; Nicolucci D; Porcelli C; D'orazi V; Greco L; Stio F; Martino G; Messinetti S
    G Chir; 1996 May; 17(5):289-91. PubMed ID: 8755233
    [No Abstract]   [Full Text] [Related]  

  • 5. When is a cystectomy necessary in carcinoma in situ?
    Herr HW
    Prog Clin Biol Res; 1989; 303():511-5. PubMed ID: 2780659
    [No Abstract]   [Full Text] [Related]  

  • 6. Radical cystectomy for BCG failure: has the timing improved in recent years?
    Brausi M
    BJU Int; 2011 Jul; 108(2):186. PubMed ID: 21718431
    [No Abstract]   [Full Text] [Related]  

  • 7. Innovative approaches for superficial bladder tumors.
    Oosterlinck W; Abi-Aad A
    Acta Urol Belg; 1996 May; 64(2):31-2. PubMed ID: 8701806
    [No Abstract]   [Full Text] [Related]  

  • 8. BCG in carcinoma in situ and superficial bladder tumors.
    Lamm DL
    Prog Clin Biol Res; 1988; 269():497-510. PubMed ID: 3293069
    [No Abstract]   [Full Text] [Related]  

  • 9. Percutaneous BCG perfusion of the upper urinary tract for carcinoma in situ.
    Studer UE; Casanova G; Kraft R; Zingg EJ
    Prog Clin Biol Res; 1990; 350():81-6. PubMed ID: 2385611
    [No Abstract]   [Full Text] [Related]  

  • 10. BCG therapy of superficial bladder tumors.
    Herr HW
    Prog Clin Biol Res; 1989; 303():369-74. PubMed ID: 2674999
    [No Abstract]   [Full Text] [Related]  

  • 11. Carcinoma in situ of the bladder.
    Herr HW
    Semin Urol; 1983 Feb; 1(1):15-22. PubMed ID: 6679095
    [No Abstract]   [Full Text] [Related]  

  • 12. Management of superficial transitional cell carcinoma of the bladder.
    Fleischmann J; Goldberg G
    Semin Urol; 1993 Nov; 11(4):193-204. PubMed ID: 8290825
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment of superficial bladder cancer.
    Grossman HB
    Compr Ther; 1995 May; 21(5):245-8. PubMed ID: 7621655
    [No Abstract]   [Full Text] [Related]  

  • 14. The limits of bacillus Calmette-Guerin for carcinoma in situ of the bladder.
    Kim JC; Steinberg GD
    J Urol; 2001 Mar; 165(3):745-56. PubMed ID: 11176460
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Conservative treatment of bladder tumors].
    J Urol (Paris); 1985; 91(10):668-89. PubMed ID: 3842975
    [No Abstract]   [Full Text] [Related]  

  • 16. Update on the Dutch Cooperative Trial: mitomycin versus bacillus Calmette-Guérin-Tice versus bacillus Calmette-Guérin RIVM in the treatment of patients with pTA-pT1 papillary carcinoma and carcinoma in situ of the urinary bladder. Dutch South East Cooperative Urological Group.
    Witjes WP; Witjes JA; Oosterhof GO; Debruyne MJ
    Semin Urol Oncol; 1996 Feb; 14(1 Suppl 1):10-6. PubMed ID: 8727805
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of bladder tumors].
    Njinou B; Dardenne B; Darimont M; Wese FX; Van Cangh PJ
    Acta Urol Belg; 1999; 67(1):6-10. PubMed ID: 10859816
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment and follow-up of superficial bladder cancer].
    Raitanen M
    Duodecim; 2002; 118(9):903-9. PubMed ID: 12238168
    [No Abstract]   [Full Text] [Related]  

  • 19. Medical management of patients with refractory carcinoma in situ of the bladder.
    Kim JC; Steinberg GD
    Drugs Aging; 2001; 18(5):335-44. PubMed ID: 11392442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [BCG immunotherapy in the treatment of superficial bladder tumors].
    Samodai L; Drinóczy M; Kolozsy Z; Mohácsi L; Dauda G; Porkoláb Z
    Orv Hetil; 1986 Oct; 127(40):2441-6. PubMed ID: 3537907
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.